Deep Brain Stimulation (DBS) for the Treatment of Parkinson's Disease

Completed · Not applicable

Conditions studied: Parkinson's Disease

In brief

The purpose of this study is to evaluate the safety and effectiveness of Boston Scientific's Vercise Deep Brain Stimulation (DBS) system in the treatment of patients with with advanced, levodopa-responsive bilateral Parkinson's disease (PD) which is not adequately controlled with medication.

Key facts

Study ID
NCT01839396
Run by
Boston Scientific Corporation
People needed
313
Starts
2013-05-17
Expected to finish
2022-12-05
Last updated by the study team
2023-07-13

Who can join

Age: 22 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.